Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 93651-93700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04234386
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer
NARecruiting
50 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2028
1 condition1 sponsor4 locations
NCT05032742
Parenting Stress mHealth
NARecruiting
60 participants
Started: Sep 15, 2021 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT04845217
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
PHASE1/PHASE2Recruiting
100 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2023
1 condition2 sponsors1 location
NCT04899908
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
PHASE2Recruiting
134 participants
Started: Sep 15, 2021 · Completed: Feb 28, 2026
16 conditions2 sponsors2 locations
NCT05006794
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies
PHASE1Active, not recruiting
145 participants
Started: Sep 15, 2021 · Completed: Mar 31, 2029
1 condition1 sponsor13 locations
NCT04831684
Novel MGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes
PHASE1/PHASE2Recruiting
90 participants
Started: Sep 15, 2021 · Completed: Apr 22, 2026
1 condition3 sponsors1 location
NCT05395767
LIVing Donor Allograft for Anterior Cruciate Ligament Reconstruction Study
NARecruiting
40 participants
Started: Sep 15, 2021 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT05198570
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
N/ARecruiting
200 participants
Started: Sep 15, 2021 · Completed: Mar 31, 2026
5 conditions2 sponsors1 location
NCT05081141
HHV8 and Solid Organ Transplantation
N/ARecruiting
250 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2025
8 conditions1 sponsor1 location
NCT04927143
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
NARecruiting
600 participants
Started: Sep 15, 2021 · Completed: Sep 30, 2026
7 conditions4 sponsors2 locations
NCT04989881
Comparison of Dry-lab Laparoscopic Training and Robotic Virtual Simulator
NARecruiting
100 participants
Started: Sep 15, 2021 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04466488
Prevent TB: Choice Architecture for TPT Delivery
NARecruiting
36 participants
Started: Sep 15, 2021 · Completed: Nov 1, 2025
2 conditions3 sponsors1 location
NCT04704544
Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE)
NAActive, not recruiting
652 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT05027776
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
PHASE3Recruiting
1,348 participants
Started: Sep 15, 2021 · Completed: Sep 29, 2026
7 conditions2 sponsors1 location
NCT04909801
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
PHASE3Active, not recruiting
338 participants
Started: Sep 15, 2021 · Completed: Sep 1, 2027
1 condition1 sponsor75 locations
NCT04347655
Assessing Systemic Circulation and LV Performance in Adults
NARecruiting
100 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04776252
Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)
PHASE3Active, not recruiting
2,000 participants
Started: Sep 15, 2021 · Completed: May 17, 2028
1 condition1 sponsor93 locations
NCT05124951
The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors
PHASE2Recruiting
150 participants
Started: Sep 15, 2021 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05111834
IRENE-G Study: Impact of Resistance Exercise and Nutritional Endorsement on GvHD Symptoms
NAActive, not recruiting
112 participants
Started: Sep 15, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT04029844
Colibri Transcatheter Aortic Heart Valve System Study
NARecruiting
30 participants
Started: Sep 15, 2021 · Completed: Jul 31, 2028
1 condition1 sponsor5 locations
NCT04884035
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
PHASE1Recruiting
174 participants
Started: Sep 15, 2021 · Completed: Dec 1, 2028
1 condition1 sponsor34 locations
NCT05123963
Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors
NARecruiting
48 participants
Started: Sep 15, 2021 · Completed: Dec 30, 2026
1 condition9 sponsors1 location
NCT05224557
Analysis of Cardiac Biomarker Racial Discrepancies
N/AEnrolling by invitation
400 participants
Started: Sep 15, 2021 · Completed: Sep 15, 2024
1 condition1 sponsor1 location
NCT04588233
Melatonin Adolescent Research Study
NARecruiting
80 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05058976
Romosozumab Use to Build Skeletal Integrity
PHASE4Active, not recruiting
184 participants
Started: Sep 15, 2021 · Completed: Sep 30, 2027
3 conditions3 sponsors1 location
NCT04877821
The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC
PHASE2Active, not recruiting
31 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05030597
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
N/ARecruiting
100 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05304858
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
N/ARecruiting
16 participants
Started: Sep 15, 2021 · Completed: Feb 29, 2028
1 condition2 sponsors1 location
NCT05585918
The R-CITY Project: A Collaborative Intervention With Teachers and Youth
NARecruiting
320 participants
Started: Sep 15, 2021 · Completed: Jul 31, 2025
1 condition4 sponsors1 location
NCT05115812
Renal Autotransplantation; Case Series
N/AEnrolling by invitation
30 participants
Started: Sep 15, 2021 · Completed: Sep 30, 2024
6 conditions1 sponsor1 location
NCT04838769
REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
NAActive, not recruiting
154 participants
Started: Sep 15, 2021 · Completed: Mar 31, 2027
1 condition1 sponsor21 locations
NCT04507854
Return to Performance Criteria Following Shoulder Instability Surgery in the Athlete.
NARecruiting
80 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT03923907
Complex Exercise Intervention to Normalize Blood Pressure and Nocturnal Dipping in Patients With Hypertension
NAActive, not recruiting
198 participants
Started: Sep 15, 2021 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT04832477
Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US
NAActive, not recruiting
500 participants
Started: Sep 15, 2021 · Completed: Feb 4, 2026
4 conditions1 sponsor1 location
NCT03968913
Biologic Therapy to Prevent Osteoarthritis After ACL Injury
EARLY_PHASE1Recruiting
32 participants
Started: Sep 15, 2021 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05082090
A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices
N/AActive, not recruiting
2,000 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2031
1 condition1 sponsor20 locations
NCT04558879
Exercise and Sleep in Parkinson's Disease
NARecruiting
60 participants
Started: Sep 15, 2021 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT04998773
Efficacy and Biomarkers of Response of TBS in Treatment Resistant Depression
NARecruiting
96 participants
Started: Sep 15, 2021 · Completed: Feb 28, 2025
2 conditions4 sponsors1 location
NCT05042063
Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease
N/ARecruiting
100 participants
Started: Sep 15, 2021 · Completed: Sep 15, 2026
7 conditions3 sponsors1 location
NCT04814381
Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)
PHASE4Recruiting
90 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors14 locations
NCT04938349
Dual Task Perturbation Training for OAwMCI
NARecruiting
142 participants
Started: Sep 14, 2021 · Completed: Aug 31, 2026
2 conditions3 sponsors1 location
NCT05033392
PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer
PHASE2Recruiting
62 participants
Started: Sep 14, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT04467801
Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy
PHASE2Recruiting
60 participants
Started: Sep 14, 2021 · Completed: Aug 31, 2025
2 conditions3 sponsors5 locations
NCT04971590
Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis
N/ARecruiting
200 participants
Started: Sep 14, 2021 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05063786
Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)
PHASE3Active, not recruiting
27 participants
Started: Sep 14, 2021 · Completed: Jun 30, 2026
1 condition4 sponsors106 locations
NCT06359301
H-34 DELTA Revision Cup
N/ARecruiting
49 participants
Started: Sep 14, 2021 · Completed: Mar 31, 2029
1 condition1 sponsor1 location
NCT04880473
Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment
NARecruiting
400 participants
Started: Sep 14, 2021 · Completed: Dec 1, 2024
1 condition1 sponsor8 locations
NCT04944576
Observational Study to Evaluate Safety and Performance of the Total Ankle Prosthesis, EasyMove®
N/AActive, not recruiting
82 participants
Started: Sep 14, 2021 · Completed: Sep 13, 2029
1 condition1 sponsor6 locations
NCT05613985
PHOTOFINISH: a Clinical Study To Evaluate The Efficacy And Safety Of the System VULNOFAST® Plus/VULNOLIGHT® In Addition To The Usual Care (UC) Vs UC Alone For The Treatment Of Infected Diabetic Foot Ulcers
NARecruiting
78 participants
Started: Sep 14, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor7 locations
NCT05785910
Adaptation of the Uniform Data Set for Telematic Administration
NAActive, not recruiting
14 participants
Started: Sep 14, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location